SIRT1 and focal segmental glomerulosclerosis: Consistent with previous studies [21], our immunohistochemistry staining results validated the reduction of Sirt1 expression in renal biopsies from patients with FSGS and DN in comparison to normal subjects or patients with MCD (Fig. 7A).